Biogen Inc (BIIB)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$116.71

Buy

$118.25

arrow-down$-4.98 (-4.09%)

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Prices updated at 06 May 2025, 12:19 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.87%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$121.81 - $115.86
$238.00 - $110.04
-
17,117.38m
11.54
-
247
1.01
1,350,822.59
-0.07
169.52m
US09062X1037
10.12
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.